home / stock / ftsv / ftsv quote
Last: | $95.51 |
---|---|
Change Percent: | 0.05% |
Open: | $95.46 |
Close: | $95.51 |
High: | $95.515 |
Low: | $95.46 |
Volume: | 693,725 |
Last Trade Date Time: | 04/06/2020 04:46:57 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$95.51 | $95.46 | $95.51 | $95.515 | $95.46 | 693,725 | 04-06-2020 |
$95.46 | $95.44 | $95.46 | $95.47 | $95.42 | 738,462 | 04-03-2020 |
$95.43 | $95.42 | $95.43 | $95.44 | $95.41 | 553,969 | 04-02-2020 |
$95.44 | $95.4 | $95.44 | $95.44 | $95.25 | 1,431,974 | 04-01-2020 |
$95.42 | $95.43 | $95.42 | $95.44 | $95.34 | 2,728,634 | 03-31-2020 |
$95.37 | $95.35 | $95.37 | $95.43 | $95.32 | 2,074,064 | 03-30-2020 |
$94.55 | $94.3 | $94.55 | $94.8 | $94.25 | 1,766,593 | 03-27-2020 |
$94.47 | $94.3 | $94.47 | $94.51 | $94.04 | 1,206,789 | 03-26-2020 |
$93.87 | $93.97 | $93.87 | $94.9 | $93 | 1,370,271 | 03-25-2020 |
$94.11 | $93.9 | $94.11 | $94.15 | $92.91 | 1,425,084 | 03-24-2020 |
$92.99 | $92.38 | $92.99 | $94.23 | $91.265 | 1,434,134 | 03-23-2020 |
$91.84 | $91.86 | $91.84 | $93.48 | $90.31 | 1,622,953 | 03-20-2020 |
$91.39 | $89.89 | $91.39 | $92.6 | $88.68 | 1,138,744 | 03-19-2020 |
$ | $43.90 | $42.31 | $44.84 | $42.08 | 226,896 | 02-12-2020 |
$ | $45.10 | $42.80 | $45.43 | $41.02 | 365,983 | 02-11-2020 |
$ | $43.33 | $44.61 | $45.39 | $42.54 | 241,900 | 02-10-2020 |
$ | $43.21 | $43.10 | $43.3799 | $42.16 | 195,888 | 02-07-2020 |
$ | $41.48 | $43.33 | $43.46 | $41.21 | 284,441 | 02-06-2020 |
$ | $40.67 | $41.67 | $43.19 | $40.61 | 636,553 | 02-05-2020 |
$ | $41.40 | $40.53 | $42.58 | $37.64 | 785,428 | 02-04-2020 |
News, Short Squeeze, Breakout and More Instantly...
The ongoing COVID-19 pandemic has caused significant disruptions to the global economy, as well as grievances for families witnessing their loved ones die from the virus. Fortunately, there's finally a light at the end of the tunnel as one investigative treatment has revealed potential efficacy ...
For years, Gilead Sciences ' (NASDAQ: GILD) stock price has been rather disappointing for investors hoping for long-term capital appreciation. While shares do boast an impressive 3.63% dividend yield, the company's revenues have experienced an enormous decline from 2015 onwards, falling over ...
Shares of Forty Seven (NASDAQ: FTSV) climbed 64.5% in March, according to data from S&P Global Market Intelligence . The immuno-oncology specialist's stock skyrocketed early in the month after it was announced that the company was on track to be purchased by Gilead Sciences...